MTOR and metabolic dysfunction-associated steatotic liver disease: Previous strategies to increase autophagic flux to counteract NAFLD used mTOR inhibitors like rapamycin to increase autophagic turnover, which in turn increased V-ATPase expression and lysosomal acidification.